Abstract:Lipids perform multiple biological functions, and reflect the physiology and pathology of cells, tissues, and organs. Here we sought to understand lipid content in relation to tumor pathology by characterizing phospholipids (PLs) and sphingolipids (SLs) in the orthotopic mouse glioma using matrix-assisted laser desorption-ionization mass spectrometry imaging (MALDI-MSI) and liquid chromatography tandem mass spectrometry (LC-MS/MS). Unsupervised clustering analysis of the MALDI-MSI data segmented the coronal tumoral brain section into ten histopathologically salient regions. Heterogeneous decrease of the common saturated phosphatidylcholines (PCs) in the tumor was accompanied by the increase of analogous PCs with one or two additional fatty acyl double-bonds, and increased lysophosphatidylcholines (LPCs). Polyunsaturated fatty acyl-PCs and ether PCs highlighted the striatal tumor margins, while the distributions of other PCs differentiated the cortical and striatal tumor parenchyma. We detected a reduction of sphingomyelin (SM) d18:1/18:0 and the heterogeneous mild increase of SM d18:1/16:0 in the tumor, while ceramides accumulated only in a small patch deep in the tumoral parenchyma. LC-MS/MS analyses of PLs and SLs complemented the MALDI-MSI observation, providing a snapshot of these lipids in the tumor. Finally, the proposed mechanisms responsible for the tumoral lipid changes were contrasted with our interrogation of gene expression in human glioma. Together, these lipidomic results unveil the aberrant and heterogeneous lipid metabolism in mouse glioma where multiple lipid-associated signaling pathways underline the tumor features, promote the survival, growth, proliferation, and invasion of different tumor cell populations, and implicate the management strategy of a multiple-target approach for glioma and related brain malignancies.

A Mass Spectrometry Imaging and Lipidomic Investigation Reveals Aberrant Lipid Metabolism in the Orthotopic Mouse Glioma